Skip to Main Content

Paper Details

Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity.
J Am Chem Soc
71
2021
2-chloro-2,2-dibromoacetamide, Di- and Trihaloacetamides, GC-376, Jun9-57-3R, Jun9-62, Jun9-62-2R, Jun9-88-6R, Mpro, SARS, SARS-, SARS-CoV-2, SARS-CoV-2 Mpro, calpain I, caplain, caspase-3, cathepsin B, cathepsin K, cathepsin L, cathepsins, cysteine, cysteine proteases, dibromoacetamide, dichloroacetamide, human, main, tribromoacetamide
Author NameAffiliation
Xiangzhi MengUniversity of Texas Health Science Center at San Antonio
Michael T MartyThe University of Arizona
  • 1 - 2

Datasets

Release 1.2